CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers

Saved in:
Bibliographic Details
Other Authors: Markert, Christoph (Other) , Burhenne, Jürgen (Other) , Weiß, Johanna (Other) , Mikus, Gerd (Other) , Haefeli, Walter E. (Other)
Format: Article (Journal)
Language:English
Published: 2014
In: Clinical pharmacology & therapeutics
Year: 2014, Volume: 95, Issue: 3, Pages: 250-251
ISSN:1532-6535
DOI:10.1038/clpt.2013.188
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/clpt.2013.188
Get full text
Author Notes:C. Markert, J. Burhenne, J. Weiss, G. Mikus and W. E. Haefeli
Description
Item Description:Gesehen am 23.02.2015
Physical Description:Online Resource
ISSN:1532-6535
DOI:10.1038/clpt.2013.188